Results 71 to 80 of about 66,412 (118)

Clinical progression parameters associated with SARS-CoV-2, influenza, and respiratory syncytial virus infections in a large US integrated healthcare population. [PDF]

open access: yesPLoS Comput Biol
Parker NT   +9 more
europepmc   +1 more source

Estimated Incidence of Hospitalisations and Deaths Attributable to Respiratory Syncytial Virus Infections in Adults in Norway between 2010 and 2019: A Time-Series Modelling Study. [PDF]

open access: yesJ Epidemiol Glob Health
Casas M   +11 more
europepmc   +1 more source

Estimating the economically justifiable price of nirsevimab versus standard of practice for the prevention of respiratory syncytial virus infections in neonates and infants in Spain: a cost-utility modelling study. [PDF]

open access: yesBMJ Public Health
Gil-Prieto R   +8 more
europepmc   +1 more source

Estimated Incidence of Hospitalisations and Deaths Attributable to Respiratory Syncytial Virus Infections in Adults in Australia Between 2010 and 2019. [PDF]

open access: yesInfluenza Other Respir Viruses
Wiid Z   +11 more
europepmc   +1 more source

Adult patients with severe respiratory syncytial virus infections in the emergency department. [PDF]

open access: yesMedicine (Baltimore)
Fistera D   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy